Mark Hulbert has long studied U.S. investment markets from the top down. This week he has a warning — and it is not about a broad stock-market crash, which investors might expect at this time of the ...

Periodic Labs came out of stealth on Tuesday with a war chest of $300 million as a seed round, backed by a tech industry who’s who: Andreessen Horowitz, DST, Nvidia, Accel, Elad Gil, Jeff Dean, Eric ...

A controversial new paper questions whether the interstellar object 3I/ATLAS is a potentially dangerous alien probe, similar to claims made about 'Oumuamua. But experts have called it "nonsense". The ...

Chances are that you have unknowingly encountered compelling online content that was created, either wholly or in part, by some version of a Large Language Model (LLM). As these AI resources, like ...

Like any crappy human writer, AI chatbots have a tendency to overuse specific words — and now, scientists are using that propensity to catch their colleagues when they secretly use it in their work.

Australian researchers are turning to nature for the next computing revolution, harnessing living cells and biological systems as potential replacements for traditional silicon chips. A new paper from ...

The Army is grappling with a staggering attrition rate among newly enlisted troops, even as recent recruiting figures suggest the service is clawing its way out of a yearslong enlistment crisis.

F or most of the past century, the United States has been the global leader in scientific discovery. In just the last five years, American scientists have won more Nobel Prizes than the rest of the ...

WASHINGTON (AP) — U.S. inflation accelerated last month as the cost of groceries, gasoline and rents rose, a disappointment for families and businesses struggling with higher costs and likely ...

Every federal agency in the U.S. is currently trying to figure out how to purge forbidden words from documents posted online, in a desperate attempt to comply with President Donald Trump’s executive ...

James is a published author with multiple pop-history and science books to his name. He specializes in history, space, strange science, and anything out of the ordinary.View full profile James is a ...

Preliminary safety and efficacy of oral azacitidine (Oral-AZA) in patients (pts) with low-/Intermediate (Int)-risk myelodysplastic syndromes (MDS): Phase 2 results from the ASTREON trial. This is an ...